NVR 7P5 (Afinitor 7.5 mg)
Generic Name: everolimus
Pill imprint NVR 7P5 has been identified as Afinitor 7.5 mg.
Afinitor is used in the treatment of neuroendocrine carcinoma; breast cancer; brain tumor; pancreatic cancer; renal angiomyolipoma (and more), and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Afinitor 7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- everolimus
- Imprint:
- NVR 7P5
- Strength:
- 7.5 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- MTOR inhibitors
Selective immunosuppressants - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- 00078-0620
- Inactive Ingredients:
- butylated hydroxytoluene
crospovidone
hypromelloses
lactose anhydrous
lactose monohydrate
magnesium stearate
More about Afinitor (everolimus)
Consumer resources
- Other brands: Zortress
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
